US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<H Shrs> HSI Weakens on Thinner Turnover; Auto Stocks Rally; JD Health Slumps Over 9%
US-Iran nuclear talks yielded no results, and the US announced it would block the Strait of Hormuz. Market rumors later suggested a new round of US-Iran talks could be held within ...
Reset
Send
The window will close in 5 seconds
<H Shrs> HSI Weakens on Thinner Turnover; Auto Stocks Rally; JD Health Slumps Over 9%
Recommend
7
Positive
7
Negative
8
 
 

US-Iran nuclear talks yielded no results, and the US announced it would block the Strait of Hormuz. Market rumors later suggested a new round of US-Iran talks could be held within days. Hong Kong equities declined today (13th). US March YoY inflation rose to 3.3%, in line with expectations. US stocks showed mixed performance last Fri (10th), with the DJIA down 0.6% and the Nasdaq up 0.4%. At the time of writing, the US 2-year Treasury yield rose to 3.824%, while the US 10-year Treasury yield climbed to 4.337%. The US Dollar Index advanced to 98.97. DJIA futures last fell 224 points or 0.5%, and Nasdaq futures dropped 170 points or 0.67%. The Shanghai Composite Index closed up 2 points or 0.06% at 3,988, while the Shenzhen Component Index rose 0.7%. Combined turnover on the Shanghai and Shenzhen exchanges totaled RMB2.15 trillion.

The HSI opened down 184 points and widened its losses to as much as 385 points, hitting a trough of 25,508. It closed down 232 points or 0.9% at 25,660. The HSCEI fell 52 points or 0.6% to 8,602, and the HSTECH declined 38 points or 0.8% to 4,822. Total market turnover decreased to HKD207.909 billion. Northbound trading turnover totaled HKD93.032 billion, while southbound funds recorded a net inflow of HKD2.249 billion today (vs a net outflow of HKD2.815 billion in the previous trading day). HKEX (00388.HK)  -2.600 (-0.637%)    Short selling $341.84M; Ratio 26.190%   slipped 0.6% to HKD405.8. Auto stocks advanced, with BYD (01211.HK)  +5.200 (+4.948%)    Short selling $1.58B; Ratio 28.735%   and NIO (09866.HK)  +3.640 (+7.465%)    Short selling $109.07M; Ratio 32.149%   rising 4.9% and 7.5%, respectively.

The Hong Kong Monetary Authority granted the first two stablecoin issuer licenses to a consortium led by HSBC and Standard Chartered. HSBC (00005.HK)  -0.900 (-0.644%)    Short selling $331.77M; Ratio 15.671%   and Standard Chartered (02888.HK)  -3.500 (-1.928%)    Short selling $5.44M; Ratio 1.992%   fell 0.6% and 1.9%, respectively. Other stablecoin-related stocks were under pressure, with Guotai Junan International (01788.HK)  -0.400 (-12.945%)    Short selling $21.93M; Ratio 1.525%   plunging 12.9%. Meanwhile, DeepTech (01384.HK)  +26.400 (+59.193%)   and Xunce (03317.HK)  +48.400 (+15.613%)   surged 59.2% and 15.6%, with turnover of HKD3.73 billion and HKD2.66 billion, respectively.

HSI Turnover Falls; Auto Stocks Rally

Among oil stocks, PetroChina (00857.HK)  +0.170 (+1.574%)    Short selling $326.28M; Ratio 30.995%   rose 1.6% and CNOOC (00883.HK)  +0.120 (+0.452%)    Short selling $377.71M; Ratio 15.472%   gained 0.5%, while energy transportation stock COSCO SHIPPING Energy (01138.HK)  -0.870 (-4.452%)    Short selling $21.01M; Ratio 3.676%   slid 4.5%. Airline stock China Eastern Airlines (00670.HK)  -0.170 (-4.326%)    Short selling $18.05M; Ratio 13.824%   fell 4.3%. Cathay Pacific (00293.HK)  -0.330 (-2.799%)    Short selling $24.01M; Ratio 21.294%   announced flight reductions to cope with high oil prices, and its shares dropped 2.8%.

CICC released a Hong Kong market strategy report today (13th), stating that over the past week, the Iran situation has rapidly evolved toward non-escalation, which is also the markets underlying consensus expectation; otherwise, markets would have experienced greater volatility in recent weeks. While the outlook for peace talks remains uncertain and the fragile balance could still be disrupted, this broadly aligns with the banks base case that there will be short-term volatility and repeated fluctuations, with April being a key period, but a complete loss of control is not the base scenario in the medium term. The bank added that the impact of high oil prices and geopolitical shocks on earnings will take time to materialize. Meanwhile, the market still holds considerable expectations for the TACO logic, believing that US President Donald Trump may compromise under pressure from midterm elections in 2H26.

1,300 Stocks Decline; JD Health Slumps

Market breadth weakened in Hong Kong. The ratio of advancing to declining main board stocks was 17 to 32 (previous trading day: 31 to 19), with 1,337 stocks falling (down 2.5%). Among HSI constituents, 22 stocks rose while 64 declined, with an advance-decline ratio of 24 to 71 (previous trading day: 62 to 34). Short selling amounted to HKD31.288 billion, representing 17.848% of the HKD175.302 billion turnover of securities eligible for short selling.

TENCENT (00700.HK)  -14.500 (-2.874%)    Short selling $927.82M; Ratio 8.927%   fell 2.9% to HKD490, with turnover of HKD10.393 billion. BABA-W (09988.HK)  -2.300 (-1.833%)    Short selling $1.14B; Ratio 18.057%   declined 1.8%. MEITUAN-W (03690.HK)  -1.150 (-1.313%)    Short selling $467.08M; Ratio 22.919%   , NTES-S (09999.HK)  -2.700 (-1.513%)    Short selling $182.17M; Ratio 26.496%   and KUAISHOU-W (01024.HK)  -0.600 (-1.329%)    Short selling $272.64M; Ratio 25.179%   dropped between 1.3% and 1.5%. Online healthcare platform stocks retreated, with ALI HEALTH (00241.HK)  -0.250 (-5.388%)    Short selling $242.83M; Ratio 34.687%   and PING AN HEALTHCARE AND TECHNOLOGY (01833.HK)  -0.590 (-4.856%)    Short selling $13.05M; Ratio 11.678%   falling 5.4% and 4.9%, while JD HEALTH (06618.HK)  -4.840 (-9.435%)    Short selling $232.10M; Ratio 33.398%   slumped 9.4%.

UBS said in a report that JD HEALTHs 1Q26 results are expected to broadly meet expectations. Pharmaceutical sales growth remained strong despite a high base, with revenue estimated to grow about 17%, in line with the companys full-year guidance. Adjusted operating margin for 1Q26 is expected to remain broadly stable, also consistent with full-year guidance. However, interest and cash-related income, as well as fair value changes in cash investment products, weighed on net profit, resulting in broadly flat adjusted net profit last quarter. (wl/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-13 16:25.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI

AASTOCKS Financial News

Related Stocks
0/0
 
SITEMAP
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
You expressly agree that the use of this app/website is at your sole risk.

AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd, Nasdaq, Inc., their respective holding companies and/or any subsidiaries of such holding companies, their Sources and/or other third party data provider(s) endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co.Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) make any express or implied offers, representations or warranties (including, without limitation, any warranty or merchantability or fitness for a particular purpose or use) regarding the Information.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) will be liable to any Subscriber or any other party for any interruption, inaccuracy, error, or omission, regardless of cause, in the Information or for any damages (whether direct or indirect, consequential, punitive, or exemplary) resulting from its use by any party.

AASTOCKS.com Limited shall not be liable for any failure or delay in performance of its obligations under this Disclaimer because of circumstances beyond its reasonable control, including but without limitation, acts of God, typhoons, rainstorms, other natural disasters, government restrictions, strikes, wars, virus outbreak, network failures or telecommunications failures.

Morningstar Disclaimer: Copyright © 2020 Morningstar, Inc. All Rights Reserved. The information, data, analyses and opinions ("Information") contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may not be copied or redistributed except as specifically authorised; (3) do not constitute investment advice; (4) are provided solely for informational purposes; and (5) are not warranted to be complete, accurate or timely. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

The information and contents contained in this app/website are based on the analyses and interpretations of publicly available information obtained from sources believed to be reliable. Such analyses and information have not been independently verified and AASTOCKS.com Limited makes no guarantees to their accuracy, completeness, timeliness or correctness.

The information, financial market data, quotes, charts, statistics, exchange rate, news, research, analysis, buy and sell ratings, Education Center and other information on this app/website should be used as references only at your own discretion. Prior to the execution of a security or any other trade based upon the Information, you are advised to consult independent professional advice to verify pricing information or to obtain more detailed market information. AASTOCKS.com Limited is not soliciting any subscriber or app/website visitor to execute any trade. Any trades executed following the said information, commentaries and/or buy/sell ratings on this app/website are taken at your own risk for your own account.

As a convenience to users, the AASTOCKS.com Limited has added a translation feature developed by Azure OpenAI to assist users in understanding information on this platform in languages other than Chinese. The translated text may lose some of its intended meaning. Some items on the site, including images containing text, videos with captioning, PDF documents, or maps may not be translated, and some features may not work in the translated versions.

The AASTOCKS.com Limited does not guarantee the accuracy of translations, and the translated text should not be considered exact. The text translated is made available on an as is and as available basis without any warranties of any kind. The AASTOCKS.com Limited will not accept any liability for damages or losses of any kind caused by the use of the translation feature.

AASTOCKS.com Limited provides the information and services on an "AS IS" basis. The information and contents on this app/website are subject to change without notice. AASTOCKS.com Limited reserves the right, in its sole discretion but without any obligation, to make improvements to, or correct any error or omissions in any portion of this app/website at any time.

The subscriber or app/website visitor agrees not to reproduce, retransmit, disseminate, distribute, broadcast, publish, circulate, sell or commercially exploit the information and contents on this app/website in any manner without the express written consent of AASTOCKS.com Limited.

Investment involves risk. You may make use of the Education Center of this website for academic reference purposes at your own discretion. AASTOCKS.com Limited cannot and does not give any assurance that the present or future buy/sell commentaries and signals on this app/website will be profitable. AASTOCKS.com Limited cannot guarantee, and the subscriber or app/website visitor should not assume, that the future performance will equal past performance.

AASTOCKS.com Limited may point to other sites that may be of interest to the subscriber or app/website visitor but for which AASTOCKS.com Limited has no responsibility and only provides this as a service to the subscriber or app/website visitor.

AASTOCKS.com Limited does not represent or endorse the accuracy or reliability of any information, advertisements or contents contained on, distributed through, or linked, downloaded or accessed from any of the services on this app/website. AASTOCKS.com Limited cannot and does not guarantee the quality or reliability of any products or information purchased or obtained by you as a result of an advertisement or any other information displayed on this app/website.

AATV is a video platform owned by AASTOCKS.com Limited.

You acknowledge that: (i) AATV is provided for information purposes only and, in particular, is not intended for trading purposes; (ii) AATV does not and none of the information contained in its program constitutes a solicitation, offer, opinion, or recommendation by us to buy or sell any security, or to provide legal, tax, accounting, or investment advice or services whether or not regarding the profitability or suitability of any security or investment; and (iii) AATV is not intended for use by, or distribution to, any person or entity in any jurisdiction or country where such use or distribution would be contrary to law or regulation.

The financial analysis or opinion expressed in the AATV programs is for reference and discussion only, and does not represent AASTOCKS.com Limited. Investors must make their own investment decisions based on their own investment objectives and financial situation. AASTOCKS.com Limited shall not, directly or indirectly, be liable, in any way, to you or any other person for any: (i) inaccuracies or errors in or omissions from AATV including, but not limited to, quotes and financial data; (ii) delays, errors, or interruptions in the transmission or delivery of AATV; or (iii) loss or damage arising therefrom or occasioned thereby, or by any reason of nonperformance.

AASTOCKS.com Limited reserves the right to change this Disclaimer at any time by posting changes online at this app/website. You are responsible for reviewing regularly information posted therein to obtain timely notice of such changes. Your continued use of this app / website after changes are posted constitutes your acceptance of this Agreement as modified by the posted changes.

The disclaimer herein shall be governed by the law of the Hong Kong Special Administrative Region of the People's Republic of China ("Hong Kong") and you agree to submit to the exclusive jurisdiction of the Hong Kong courts.

In the event of any discrepancy between the Chinese and English versions, the English version shall prevail.

Last updated on 9 February 2026.